---
schema_version: "secwatch.filing_event.v1"
accession: "0001013762-24-003342"
form_type: "8-K"
ticker: "COCH"
cik: "0001840877"
company_name: "Envoy Medical, Inc."
filed_at: "2024-08-01T23:59:59+00:00"
generated_at: "2026-05-31T14:00:16.183269+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Envoy Medical backs bipartisan Senate bill to classify implanted middle ear devices as prosthetics for Medicare coverage

## Summary
- Senate bill S.4829 (Hearing Device Coverage Clarification Act) introduced July 29 by Klobuchar (D-MN) and Lankford (R-OK).
- Bill seeks to clarify that implanted active middle ear hearing devices are prosthetics, not hearing aids, removing Medicare hearing aid exclusion.
- Envoy's Esteem FI-AMEI is the only FDA-approved fully implanted active middle ear device; company expects increased competition if bill passes.
- House companion legislation already introduced; Envoy believes combined efforts raise chances of enactment.
- CEO Brent Lucas says bill would expand patient access and spur innovation in the segment.

## SEC filing metadata
- accession: 0001013762-24-003342
- form_type: 8-K
- ticker: COCH
- cik: 0001840877
- company_name: Envoy Medical, Inc.
- filed_at: 2024-08-01T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840877/000101376224003342/0001013762-24-003342-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840877/000101376224003342/ea021039601-8k_envoy.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001013762-24-003342
- JSON: https://secwatch.observer/filing/0001013762-24-003342.json
- Plain text: https://secwatch.observer/filing/0001013762-24-003342.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.